Vir Biotechnology, Inc. which can be found using ticker (VIR) now have 7 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 100 and 27 with the average target price sitting at $49.71. Now with the previous closing price of $25.34 this now indicates there is a potential upside of 96.2%. It’s also worth noting that there is a 50 day moving average of $24.17 and the 200 moving average now moves to $24.63. The company has a market cap of 3.45B. The stock price is currently at: 25.74 USD
The potential market cap would be $6,765,127,011 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 3.36 and a -6.46% return on assets.
